Navigation Links
Suneva Medical to Pursue Expanded Indications for Artefill® With Launch of Phase III Acne Scar Study

SAN DIEGO, Jan. 11, 2012 /PRNewswire/ -- Suneva Medical, a privately-held aesthetic medical device company, today announced that it is launching a multi-center study to investigate the efficacy of Artefill for the treatment of acne scars. The 150-patient prospective study is being conducted at 10 centers throughout the U.S. and will enroll its first patient by February.  

"Acne can have lasting effects on a patient's self-esteem, especially when we are limited in our ability to permanently treat the resulting scars," said study investigator Ava Shamban, M.D. "Artefill is a great solution for my regular filler patients who want to correct facial wrinkles with natural, long-lasting results and we are optimistic about its effectiveness with this new patient population."

According to the American Dermatology Association, acne is the most common skin disorder in the United States, affecting 40 million to 50 million Americans. By mid-teens, more than 40 percent of adolescents have acne or acne scarring, which requires treatment by a dermatologist. Studies have reported the incidence of acne scarring in the general population to be 1 to 11 percent[1].

"Acne scarring impacts patients both physically and emotionally as it's a direct reminder of the issues that affected them during their earlier years.  However, there is no permanent solution on the market today to address this widespread cosmetic issue. We believe Artefill's unique composition may provide these patients a real solution for what many thought would be a lifelong problem," commented Nicholas Teti, Chairman and CEO of Suneva Medical. He continued, "We are pleased to be working with a strong and prominent group of investigators on this trial as we look to expand the indications for Artefill."

Approved in 2006, Artefill is a long-lasting, dermal filler. It is composed of bovine collagen and unique microspheres and includes lidocaine for improved patient comfort. This distinct formulation offers patients long-lasting wrinkle correction. To date over 30,000 patients have been treated.

Patients interested in additional information about this trial may visit

About Suneva Medical

Suneva Medical, Inc. is a medical technology company focused on developing, manufacturing and commercializing novel, differentiated aesthetic products for the dermatology, plastic and cosmetic surgery markets. The Company's long-lasting injectable product is marketed as Artefill® in the U.S. and Bellafill™ in Canada to correct facial wrinkles. For more information visit or

[1] Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J. 1979;1(6171): 1109–1110. Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol. 1999:41:577–580.

Kate Gilbert 
Vice President, Marketing 
Suneva Medical 
(858) 550-9999 x7844 
Kellie Walsh 
(914) 315-6072

SOURCE Suneva Medical
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Suneva Medical Signs Multi-Million Dollar Line of Credit Agreement with Western Technology Investment
2. Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer
3. Suneva Medical Announces Canadian Approval of Bellafill™
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Globus Medical Raises $110 Million in Series E Financing Round
8. Quark Pharmaceuticals Appoints New Chief Medical Officer
9. Boston University Biomedical Engineers Find Chink in Bacterias Armor
10. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
11. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
Post Your Comments:
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
(Date:6/23/2016)... -- The Biotechnology industry might still be ... opportunities to investors. assesses the recent performances of ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ... complimentary trade alerts at: ...
(Date:6/23/2016)... Leading BioSciences Inc., a clinical-stage biopharmaceutical ... from a breakdown of the mucosal barrier, today ... as chief executive officer. Mr. Doyle, a ... and board of directors, previously served as chief ... provide continued leadership and strategic direction to the ...
Breaking Medicine Technology:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):